SCOPUS 정보 검색 플랫폼

Volumn 51, Issue 3, 2002, Pages 171-177

Anti-renal cell carcinoma chimeric antibody G250: Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity

(6) Liu, Zhanqi a Smyth, Fiona E a Renner, Christoph a Lee, Fook Thean a Oosterwijk, Egbert b Scott, Andrew M a

a LUDWIG INSTITUTE FOR CANCER RESEARCH (Australia)

b RADBOUD UNIVERSITY MEDICAL CENTER (Netherlands)

Author keywords

Antibody dependent cellular cytotoxicity; G250; Interferon; Interleukin 2; Monoclonal antibody; Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY G250; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CELL ACTIVITY; CELL CULTURE; CELL MEDIATED CYTOTOXICITY; CELL STIMULATION; CHIMERA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; EFFECTOR CELL; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LYMPHOKINE ACTIVATED KILLER CELL; MONONUCLEAR CELL; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; CELL SEPARATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; IMMUNOTHERAPY; INTERFERON TYPE II; INTERFERONS; INTERLEUKIN-2; KIDNEY NEOPLASMS; KILLER CELLS, NATURAL; MICE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0036217460 PISSN: 03407004 EISSN: None Source Type: Journal
DOI: 10.1007/s00262-002-0268-4 Document Type: Article

Times cited : (55)

References (30)

1
- 0030756133
- Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients
- (1997) Clin Cancer Res , vol.3 , pp. 1277
- Albertini, M.R.¹ Hank, J.A.² Schiller, J.H.³ Khorsand, M.⁴ Borchert, A.A.⁵ Gan, J.⁶ Bechhofer, R.⁷ Storer, B.⁸ Reisfeld, R.A.⁹ Sondel, P.M.¹⁰

2
- 0031463916
- Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: Clinical results and immunologic correlates of response
- (1997) J Immunother , vol.20 , pp. 301
- Bukowski, R.M.¹ Olencki, T.² Wang, Q.³ Peereboom, D.⁴ Budd, G.T.⁵ Elson, P.⁶ Sandstrom, K.⁷ Tuason, L.⁸ Rayman, P.⁹ Tubbs, R.¹⁰ McLain, D.¹¹ Klein, E.¹² Novick, A.¹³ Finke, J.¹⁴

3
- 0033060774
- Immunotherapy in renal cell carcinoma
- (1999) Oncology , vol.13 , pp. 801
- Bukowski, R.M.¹

4
- 0028904693
- Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia
- (1995) Clin Cancer Res , vol.1 , pp. 63
- Caron, P.C.¹ Lai, L.T.² Scheinberg, D.A.³

5
- 0031724558
- Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma
- (1998) Clin Cancer Res , vol.4 , pp. 2729
- Divgi, C.R.¹ Bander, N.H.² Scott, A.M.³ O'Donoghue, J.A.⁴ Sgouros, G.⁵ Welt, S.⁶ Finn, R.D.⁷ Morrissey, F.⁸ Capitelli, P.⁹ Williams, J.M.¹⁰ Deland, D.¹¹ Nakhre, A.¹² Oosterwijk, E.¹³ Gulec, S.¹⁴ Graham, M.C.¹⁵ Larson, S.M.¹⁶ Old, L.J.¹⁷

6
- 0033074437
- Renal cell carcinoma: Management of advanced disease
- (1999) J Urol , vol.161 , pp. 381
- Figlin, R.A.¹

7
- 7144255510
- Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma
- Canadian Urologic Oncology Group
- (1998) N Engl J Med , vol.338 , pp. 1265
- Gleave, M.E.¹ Elhilali, M.² Fradet, Y.³ Davis, I.⁴ Venner, P.⁵ Saad, F.⁶ Klotz, L.H.⁷ Moore, M.J.⁸ Paton, V.⁹ Bajamonde, A.¹⁰

8
- 0034099829
- Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250
- (2000) Int J Cancer , vol.85 , pp. 865
- Grabmaier, K.¹ Vissers, J.L.² De Weijert, M.C.³ Oosterwijk-Wakka, J.C.⁴ Van Bokhoven, A.⁵ Brakenhoff, R.H.⁶ Noessner, E.⁷ Mulders, P.A.⁸ Merkx, G.⁹ Figdor, C.G.¹⁰ Adema, G.J.¹¹ Oosterwijk, E.¹²

9
- 0032527921
- Human renal cell carcinoma antigen-specific CTLs: Antigen-driven selection and long-term persistence in vivo
- (1998) Cancer Res , vol.58 , pp. 3078
- Jantzer, P.¹ Schendel, D.J.²

10
- 0031846011
- A randomized phase II trial of interleukin-2 and interleukin-2-interferon alpha in advanced renal cancer
- (1998) Br J Cancer , vol.78 , pp. 366
- Jayson, G.C.¹ Middleton, M.² Lee, S.M.³ Ashcroft, L.⁴ Thatcher, N.⁵

11
- 0031963462
- Low-dose intravenous bolus interleukin-2 with interferon-alpha therapy for metastatic melanoma and renal cell carcinoma
- (1998) J Immunother , vol.21 , pp. 56
- Karp, S.E.¹

12
- 0029587051
- Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy
- (1995) Br J Cancer , vol.72 , pp. 1364
- King, D.J.¹ Antoniw, P.² Owens, R.J.³ Adair, J.R.⁴ Haines, A.M.⁵ Farnsworth, A.P.⁶ Finney, H.⁷ Lawson, A.D.⁸ Lyons, A.⁹ Baker, T.S.¹⁰

13
- 0031403224
- Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma
- (1997) Br J Urol , vol.80 , pp. 543
- Kowalczyk, D.¹ Skorupski, W.² Kwias, Z.³ Nowak, J.⁴

14
- 0030835841
- Spontaneous regression of metastatic renal cancer. Case report and literature review
- (1997) Am J Clin Oncol , vol.20 , pp. 416
- Lokich, J.¹

15
- 15844364381
- Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity
- (1996) Clin Cancer Res , vol.2 , pp. 669
- Meropol, N.J.¹ Porter, M.² Blumenson, L.E.³ Lindemann, M.J.⁴ Perez, R.P.⁵ Vaickus, L.⁶ Loewen, G.M.⁷ Creaven, P.J.⁸ Wilkes, K.A.⁹ Giedlin, M.A.¹⁰ Caligiuri, M.A.¹¹

16
- 0031660981
- Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate- dose pulsing
- (1998) Cancer Immunol Immunother , vol.46 , pp. 318
- Meropol, N.J.¹ Barresi, G.M.² Fehniger, T.A.³ Hitt, J.⁴ Franklin, M.⁵ Caligiuri, M.A.⁶

17
- 0028016154
- Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma
- (1994) Clin Exp Immunol , vol.97 , pp. 321
- Mitropoulos, D.¹ Kooi, S.² Rodriguez-Villanueva, J.³ Platsoucas, C.D.⁴

18
- 52649149913
- 51Cr release assay of antibody-dependent cell-mediated cytotoxicity (ADCC)
- Colignan JE, Kruisbeek AM, Margulies DD, Shevach EM, Strober W (eds). Greene Publishing, Wiley Interscience, New York
- (1991) Current protocols in immunology , pp. 7-271
- Nelson, D.L.¹ Kurman, C.C.² Serbousek, D.E.³

19
- 0022502868
- Monoclonal antibody G250 recognizes a determinant present in renal- cell carcinoma and absent from normal kidney
- (1986) Int J Cancer , vol.38 , pp. 489
- Oosterwijk, E.¹ Ruiter, D.J.² Hoedemaeker, P.J.³ Pauwels, E.K.⁴ Jonas, U.⁵ Zwartendijk, J.⁶ Warnaar, S.O.⁷

20
- 0027462558
- Antibody localization in human renal cell carcinoma: A phase I study of monoclonal antibody G250
- (1993) J Clin Oncol , vol.11 , pp. 738
- Oosterwijk, E.¹ Bander, N.H.² Divgi, C.R.³ Welt, S.⁴ Wakka, J.C.⁵ Finn, R.D.⁶ Carswell, E.A.⁷ Larson, S.M.⁸ Warnaar, S.O.⁹ Fleuren, G.J.¹⁰

21
- 0029189916
- Radiolabeled monoclonal antibody G250 in renal-cell carcinoma
- (1995) World J Urol , vol.13 , pp. 186
- Oosterwijk, E.¹ Debruyne, F.M.²

22
- 0028947939
- The use of monoclonal antibody G250 in the therapy of renal-cell carcinoma
- (1995) Semin Oncol , vol.22 , pp. 34
- Oosterwijk, E.¹ Debruyne, F.M.² Schalken, J.A.³

23
- 0028111173
- Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment
- (1994) Oncogene , vol.9 , pp. 2877
- Pastorek, J.¹ Pastorekova, S.² Callebaut, I.³ Mornon, J.P.⁴ Zelnik, V.⁵ Opavsky, R.⁶ Zat'ovicova, M.⁷ Liao, S.⁸ Portetelle, D.⁹ Stanbridge, E.J.¹⁰

24
- 0028266553
- Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2
- (1994) J Am Med Assoc , vol.271 , pp. 907
- Rosenberg, S.A.¹ Yang, J.C.² Topalian, S.L.³ Schwartzentruber, D.J.⁴ Weber, J.S.⁵ Parkinson, D.R.⁶ Seipp, C.A.⁷ Einhorn, J.H.⁸ White, D.E.⁹

25
- 0030659504
- Antibody-based immunological therapies
- (1997) Curr Opin Immunol , vol.9 , pp. 717
- Scott, A.M.¹ Welt, S.²

26
- 0031042925
- Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma
- (1997) Clin Cancer Res , vol.3 , pp. 17
- Soiffer, R.J.¹ Chapman, P.B.² Murray, C.³ Williams, L.⁴ Unger, P.⁵ Collins, H.⁶ Houghton, A.N.⁷ Ritz, J.⁸

27
- 17544404888
- Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250
- (1997) J Clin Oncol , vol.15 , pp. 1529
- Steffens, M.G.¹ Boerman, O.C.² Oosterwijk-Wakka, J.C.³ Oosterhof, G.O.⁴ Witjes, J.A.⁵ Koenders, E.B.⁶ Oyen, W.J.⁷ Buijs, W.C.⁸ Debruyne, F.M.⁹ Corstens, F.H.¹⁰ Oosterwijk, E.¹¹

28
- 0032694512
- Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250
- (1999) Clin Cancer Res , vol.5
- Steffens, M.G.¹ Boerman, O.C.² De Mulder, P.H.³ Oyen, W.J.⁴ Buijs, W.C.⁵ Witjes, J.A.⁶ Van den Broek, W.J.⁷ Oosterwijk-Wakka, J.C.⁸ Debruyne, F.M.⁹ Corstens, F.H.¹⁰ Oosterwijk, E.¹¹

29
- 0030017852
- Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors
- (1996) J Immunother Emphasis Tumor Immunol , vol.19 , pp. 184
- Surfus, J.E.¹ Hank, J.A.² Oosterwijk, E.³ Welt, S.⁴ Lindstrom, M.J.⁵ Albertini, M.R.⁶ Schiller, J.H.⁷ Sondel, P.M.⁸

30
- 0030867401
- Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma
- (1997) Clin Exp Immunol , vol.109 , pp. 501
- Van den Hove, L.E.¹ Van Gool, S.W.² Van Poppel, H.³ Baert, L.⁴ Coorevits, L.⁵ Van Damme, B.⁶ Ceuppens, J.L.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.